CTCs are ideal for creating preclinical models, especially 3D organoid cultures, for drug screening, disease modelling, genome editing, and organoid biobanks. The increased need for preventative medicine and companion diagnostics, as well as the rising incidence of cancer, are driving the circulating tumor cells market forward. Circulating Tumor Cells Market Scope: The most recent...